Impairment losses on securities ¥352 million
First written in FY2019-Q1. 8 of 22 entries say "Worsened", first in FY2020. Latest entry: FY2026.
The whole theme swung hardest in 2025: 2 of 11 companies on the "Worse" side.
8 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「The impairment charge for the consolidated fiscal year was ¥8 million, all of which related to equities.」
The impairment charge on securities decreased from ¥57 million in the previous fiscal year to ¥8 million. - FY2026-H1WorsenedAnnual report
「The impairment charge for the current interim consolidated accounting period was ¥8 million, all of which related to equities.」
No impairment charge on securities was recorded in the interim period of the previous fiscal year, whereas an impairment charge of ¥8 million was recorded on equities in the current interim period. - FY2025WorsenedAnnual report
「The impairment charge for the consolidated fiscal year was ¥57 million, all of which related to equities.」
No impairment charge on securities was recorded in the previous fiscal year, whereas an impairment charge of ¥57 million was recorded on equities in the current fiscal year. - FY2025-H1RestatedAnnual report
「No impairment charges were recorded for the current interim consolidated accounting period.」
No impairment charge on securities was disclosed for the current interim consolidated accounting period. - FY2024-Q1MitigatedAnnual report
「There were no impairment losses for the first quarter of the fiscal year.」
An impairment charge of ¥271 million on securities was recorded in the previous fiscal year, whereas no impairment charge was recorded for the first quarter of the current fiscal year. - FY2023WorsenedAnnual report
「The impairment charge for the consolidated fiscal year was ¥271 million, including ¥244 million on equities and ¥27 million on bonds.」
The impairment charge on securities increased from ¥109 million in the previous fiscal year to ¥271 million. - FY2023-Q3WorsenedAnnual report
「The impairment charge for the first nine months of the current consolidated fiscal year was ¥245 million, all of which related to equities.」
Following an impairment charge of ¥109 million on securities in the previous fiscal year and no charge in the first nine months of the previous fiscal year, an impairment charge of ¥245 million was recorded on equities in the first nine months of the current fiscal year. - FY2023-Q2MitigatedAnnual report
「No impairment charges were recorded for the current interim consolidated accounting period.」
An impairment charge of ¥109 million on securities was recorded in the previous fiscal year, whereas no impairment charge was recorded for the current interim period. - FY2023-Q1MitigatedAnnual report
「There were no impairment losses for the first quarter of the fiscal year.」
An impairment charge of ¥109 million on securities was recorded in the previous fiscal year, whereas no impairment charge was recorded for the first quarter of the current fiscal year. - FY2022WorsenedAnnual report
「The impairment charge for the consolidated fiscal year was ¥109 million, including ¥97 million on equities and ¥11 million on bonds.」
The impairment charge on securities increased from ¥18 million in the previous fiscal year to ¥109 million. - FY2022-Q2WorsenedAnnual report
「The impairment charge for the current interim consolidated accounting period was ¥97 million, all of which related to equities.」
The impairment charge on securities increased from ¥18 million in the previous fiscal year, with ¥97 million recorded on equities in the current interim period. - FY2022-Q1WorsenedAnnual report
「The impairment charge for the first nine months of the current consolidated fiscal year was ¥408 million, all of which related to equities.」
The impairment charge increased from ¥18 million in the previous fiscal year, with an impairment charge of ¥408 million recorded on equities in the current quarter. - FY2021MitigatedAnnual report
「The impairment charge for the consolidated fiscal year was ¥18 million, including ¥12 million on equities and ¥6 million on bonds.」
The impairment charge on securities fell sharply from ¥1,506 million in the previous fiscal year to ¥18 million. - FY2021-Q2Updated the interim impairment charge on securitiesAnnual report
「The impairment charge for the current interim consolidated accounting period was ¥12 million, all of which related to equities.」
After recording an impairment charge of ¥1,506 million on securities in the previous fiscal year, an impairment charge of ¥12 million on equities was recorded for the current interim period. - FY2021-Q1MitigatedAnnual report
「There were no impairment losses for the first quarter of the fiscal year.」
An impairment charge of ¥1,506 million on securities was recorded in the previous fiscal year, whereas no impairment charge was recorded for the first quarter of the current fiscal year. - FY2020WorsenedAnnual report
「The impairment charge for the consolidated fiscal year was ¥1,506 million, including ¥1,502 million on equities and ¥3 million on bonds.」
The impairment charge on securities increased from ¥485 million in the previous fiscal year to ¥1,506 million. - FY2020-Q3RestatedAnnual report
「Impairment losses for the first 9 months of the fiscal year totaled ¥3 million, all of which related to bonds.」
The impairment charge on securities was ¥3 million, unchanged from the interim disclosure, and continues to be disclosed as relating entirely to bonds. - FY2020-Q2Recognized ¥3 million in impairment losses on securitiesAnnual report
「Impairment losses for the interim period totaled ¥3 million, all of which related to bonds.」
While there were no impairment losses in the first quarter of the previous fiscal year, the Group recognized ¥3 million in impairment losses on bonds for the interim period. - FY2020-Q1MitigatedAnnual report
「There were no impairment losses for the first quarter of the fiscal year.」
The Group had recognized ¥485 million in impairment losses on securities in the previous fiscal year, but disclosed no impairment losses for the first quarter of the current fiscal year. - FY2019-Q3Updated impairment losses to ¥412 millionAnnual report
「Impairment losses for the first 9 months of the fiscal year totaled ¥412 million, all of which related to equities.」
The Group disclosed impairment losses on securities of ¥412 million for the first 9 months of the fiscal year, updating the cumulative amount from ¥61 million in the previous interim period. - FY2019-Q2Updated impairment losses to ¥61 millionAnnual report
「Impairment losses for the interim period totaled ¥61 million, all of which related to equities.」
The Group recognized ¥61 million in impairment losses on securities for the interim period, all of which related to equities. - FY2019-Q1First statedAnnual report
「Impairment losses for the first quarter of the fiscal year totaled ¥352 million, all of which related to equities.」
The Group recognized ¥352 million in impairment losses on securities in the first quarter, all of which related to equities.